AZD0328
Appearance
From Wikipedia, the free encyclopedia
Chemical compound
![]() | |
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
Chemical and physical data | |
Formula | C13H16N2O |
Molar mass | 216.284 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
AZD0328 is an experimental drug. It is a selective α7 nicotinic receptor agonist that enhances cortical dopamine release and improves learning and attentional processes in rats.[1]
References
[edit]- ^ Sydserff S, Sutton EJ, Song D, Quirk MC, Maciag C, Li C, et al. (October 2009). "Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes". Biochemical Pharmacology. 78 (7): 880–8. doi:10.1016/j.bcp.2009.07.005. PMID 19615981.
|
Retrieved from "https://en.wikipedia.org/w/index.php?title=AZD0328&oldid=1204629255"
Hidden categories:
- Articles with short description
- Short description matches Wikidata
- Drugs with non-standard legal status
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs missing an ATC code
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- All stub articles